Cargando…
A tumour spheroid model for antibody-targeted therapy of micrometastases.
Human neuroblastoma cells grown as tumour spheroids were briefly incubated with a conjugate of 131I and an anti-human neuroectodermal monoclonal antibody UJ13A. Unbound 131I was removed by washing and the spheroids observed in culture conditions for up to 4 weeks. Spheroid response to irradiation wa...
Autores principales: | Walker, K. A., Murray, T., Hilditch, T. E., Wheldon, T. E., Gregor, A., Hann, I. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246487/ https://www.ncbi.nlm.nih.gov/pubmed/3166889 |
Ejemplares similares
-
Identification of novel drugs to target dormant micrometastases
por: Hurst, Robert E., et al.
Publicado: (2015) -
The effect of adriamycin and 4'-deoxydoxorubicin on cell survival of human lung tumour cells grown in monolayer and as spheroids.
por: Kerr, D. J., et al.
Publicado: (1986) -
Radiation doses from (161)Tb and (177)Lu in single tumour cells and micrometastases
por: Alcocer-Ávila, Mario E., et al.
Publicado: (2020) -
131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.
por: Gaze, M. N., et al.
Publicado: (1992) -
Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.
por: Ménard, S., et al.
Publicado: (1994)